BusinessMelinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin InfectionsBy Nasdaq OMXOct 24, 2016, 12:00 PM UTC
BusinessMelinta Therapeutics Initiates Phase 3 Study of Baxdela in Hospital-Treated Community-Acquired Bacterial PneumoniaBy Nasdaq OMXJan 6, 2016, 1:00 PM UTC